Devansh Mishra’s Latest Research Highlights Hypercoagulable State in COPD
Devansh Mishra, Associate at Trainee Research AssoCiation of KGMU (TRACK), shared a post on LinkedIn:
“New Publication Alert!
Thrilled to share our latest research article, “Evaluation of Prothrombotic Biomarkers in Stable and Exacerbation Phases of Chronic
Obstructive Pulmonary Disease: A Cross-Sectional Study,” published in Cureus.
Chronic Obstructive Pulmonary Disease (COPD) remains a major global health burden, and acute exacerbations (AECOPD) significantly worsen morbidity and mortality. Our study explores the role of prothrombotic biomarkers—fibrinogen, CRP, D-dimer, and vWF—in identifying and differentiating stable and exacerbation phases of COPD.
We found that AECOPD is associated with a distinct hypercoagulable state, emphasizing the growing evidence that inflammation and thrombosis are tightly linked in disease progression. These findings not only shed light on potential diagnostic and prognostic biomarkers but also open pathways for early risk stratification and targeted therapy.
Grateful to my mentors Prof. Virendra Atam sir, Prof. Shyam chand Chaudhary sir, and Dr. Jay Tewari boss for their invaluable guidance and support throughout this work.
Proud to contribute to the evolving understanding of COPD pathophysiology and its clinical management.”
Title: Evaluation of Prothrombotic Biomarkers in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease: A Case-Control Study
Authors: Kamlesh K. Gupta, Shantanu Singh, Virendra Atam, Devansh Mishra, Jay Tewari, Shyam C. Chaudhary, Ajay Patwa

Read full article here
Stay updated with Hemostasis Today.
-
Aug 3, 2026, 16:01Your First Steps After an ITP Diagnosis – ITP Support Association
-
Aug 3, 2026, 15:33Christina Crossette-Thambiah: Scientific Excellence and Mentorship at ISTH 2026
-
Aug 3, 2026, 15:22Connie Montgomery: Why Global Support is Essential for the HFA Black Voices Initiative
-
Aug 3, 2026, 15:18Ifeanyichukwu Ifechidere: The DOAC Monitoring Masterclass
-
Aug 3, 2026, 15:02David McIntosh: UK Plasma Action – a Founder’s Reflections
-
Aug 3, 2026, 14:49Ney Carter Borges: Targeting the Gut Microbiome to Prevent Atrial Fibrillation
-
Aug 3, 2026, 13:42Immune Thrombocytopenia: Moving Beyond Platelet Counts Toward Durable Remission
-
Aug 3, 2026, 13:28Aboo Shama Khan: Pulmonary Embolism – A Medical Emergency Every Nurse Must Recognize
-
Aug 3, 2026, 13:08Ashwin Patel: Evaluating Red Cell Function Post-Treatment in SCD Patients